Coca-Cola's Cocaine Years and the Pharmacist Who Sold the Formula for $2,300

In May 1886, a fifty-five-year-old Atlanta pharmacist named John Stith Pemberton mixed a brown syrup in his backyard and carried a jug of it down the road to Jacobs' Pharmacy. The pharmacy's soda fountain was diluting it five-to-one with carbonated water and selling it to customers for five cents a glass. By the end of the year Pemberton had sold roughly twenty-five gallons of the syrup. By the end of his life — two years later — he had sold off almost every share of the company that would become Coca-Cola, in chunks, often for sums under one hundred dollars, to whoever in Atlanta would give him cash that week.

The drink that John Pemberton invented contained two stimulants. The kola nut, imported from West Africa, contributed the caffeine. The other was extracted from the leaves of the South American coca plant, and was, in concentrated form, cocaine.

Why a Civil War veteran was inventing patent medicines

Pemberton had served as a cavalry officer in the Confederate Army. In April 1865, in one of the final engagements of the Civil War, a Union sabre tore open his chest. He survived but was prescribed morphine for the pain, and like many veterans of his era, he developed a morphine addiction that lasted the rest of his life.

In the 1880s, Pemberton was a moderately successful pharmacist who, like most pharmacists of the period, made his real money formulating "patent medicines" — proprietary tonic formulations that were sold without prescription, often making sweeping medical claims, often containing alcohol, opium, or cocaine. The line between a beverage and a medicine in the 1880s was, for most American buyers, almost nonexistent. A drink at the soda fountain was both a refreshment and, sincerely, a treatment.

Pemberton's first commercial success in the patent-medicine business was a drink he called Pemberton's French Wine Coca. It was modelled on a then-popular European product called Vin Mariani — Bordeaux wine infused with coca leaf — which had been endorsed by Pope Leo XIII, Queen Victoria, and Thomas Edison. Pemberton's version added the kola nut. He marketed it, with no irony at all, as a cure for morphine addiction, neurasthenia, headache, and impotence.

Then Atlanta, in 1885, passed a local prohibition ordinance. Pemberton's wine-based product became unsellable. He spent the spring of 1886 reformulating it without the alcohol. The result, sweetened with sugar and carbonated, was a soft drink. He kept the coca leaf and the kola nut. The two ingredients gave him the name.

How much cocaine, exactly

This is the part of the story most often misunderstood. The cocaine content of original Coca-Cola was not what a modern reader imagines when hearing "cocaine in a soft drink." It was a fluid extract from coca leaves containing roughly nine milligrams of cocaine per serving — comparable to a recreational dose, but sub-clinical compared to the powdered cocaine that would become a street drug in subsequent decades.

By 1903, social opposition to cocaine in consumer products had reached the point where the company removed nearly all of it. They did not, however, remove the coca leaf entirely. To this day, Coca-Cola contains an extract of the coca leaf — processed by a single, federally licensed company in Maywood, New Jersey, which strips the cocaine alkaloid before sending the spent leaf to Coca-Cola's flavour kitchen. The cocaine itself is sold to pharmaceutical companies for medical anaesthetic use.

The trace coca extract is one of the few ingredients in the formula that has remained genuinely consistent for over a century.

The pharmacist who sold his future for grocery money

Pemberton was an addict. He needed cash, regularly and unpredictably, to support his morphine habit. By 1887, his drink was selling well enough that he could have built a serious business around it. Instead, he began selling fractional ownership to other Atlanta businessmen — sometimes the same fractions to multiple buyers, in a series of transactions that would later require months of legal untangling.

The most consequential of these transactions was with a wholesale druggist named Asa Griggs Candler, who began acquiring shares in 1888, and within two years had assembled — through a combination of legitimate purchases, settlement of disputed claims, and consolidation of competing ownership stakes — full ownership of the Coca-Cola formula and the company that produced it. The total Candler paid, across all the various Pemberton-era transactions, has been estimated at approximately $2,300.

John Pemberton died in August 1888, of stomach cancer, at fifty-seven. He was so insolvent at the time of his death that his son had to sell his pharmacy to cover funeral costs. The son, Charley, who had also been struggling with addiction, would die six years later in similar poverty.

By contrast, Asa Candler, who had assembled the company for $2,300, sold Coca-Cola in 1919 for twenty-five million dollars. Adjusted for inflation, that is approximately five hundred million in today's dollars. The buyer was a syndicate of Atlanta bankers led by Ernest Woodruff, whose family would control the company for the next century and become one of the wealthiest families in the American South.

The lesson the company never tells

Coca-Cola's official corporate history, which the company has been telling for over a century, follows a familiar arc: a humble Atlanta pharmacist invents a beloved beverage, the country embraces it, the business grows. The actual story is darker and more interesting. It is the story of an addicted veteran inventing a stimulant drink to medicate himself, selling the rights for grocery money to keep his addiction supplied, and dying before the product became globally significant. It is the story of a buyer — Candler — who recognised, more clearly than the inventor, what the formula was actually worth.

The deeper pattern in Pemberton's story is one that recurs throughout American business history. The inventor of a thing rarely captures its value. The person who recognises what the thing can become — and who has the financial sophistication, the patience, and (often) the ruthlessness to consolidate it — is the person whose name eventually appears on the company door. In Coca-Cola's case, that person was Asa Candler, then Ernest Woodruff, then a long succession of professional managers. None of them were John Pemberton.

The most valuable consumer brand on the planet was built, it turns out, on an addict's pain medication. Almost no one who drinks one today knows the story of the man who invented it.